GHP Investment Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$204 Hold
24
﹤0.01% 1187
2026
Q1
$131 Hold
24
﹤0.01% 1269
2025
Q4
$168 Hold
24
﹤0.01% 958
2025
Q3
$186 Hold
24
﹤0.01% 926
2025
Q2
$210 Hold
24
﹤0.01% 929
2025
Q1
$192 Hold
24
﹤0.01% 931
2024
Q4
$219 Hold
24
﹤0.01% 961
2024
Q3
$221 Hold
24
﹤0.01% 950
2024
Q2
$235 Hold
24
﹤0.01% 947
2024
Q1
$363 Hold
24
﹤0.01% 810
2023
Q4
$518 Hold
24
﹤0.01% 808
2023
Q3
$445 Buy
+24
New +$560 ﹤0.01% 908
2022
Q2
Sell
-75
Closed -$5K 1020
2022
Q1
$5K Buy
+75
New +$5.4K ﹤0.01% 828

Other funds holding TDOC

GHP Investment Advisors's TDOC Position: Q2 2026 in Review

GHP Investment Advisors held its Teladoc Health (TDOC) position steady in Q2 2026 at 24 shares worth $204. The position accounts for ﹤0.01% of the portfolio, ranked #1187.

GHP Investment Advisors first reported a position in TDOC in Q1 2022 and has held it in 13 quarters since. The position peaked at $5K in Q1 2022. 95 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • GHP Investment Advisors held 24 shares of Teladoc Health worth $204 as of Q2 2026.
  • GHP Investment Advisors left its Teladoc Health share count unchanged in Q2 2026.
  • Teladoc Health made up ﹤0.01% of GHP Investment Advisors's portfolio in Q2 2026, its #1187 holding.
  • GHP Investment Advisors first reported a position in Teladoc Health in Q1 2022 and has held it in 13 quarters since.
  • GHP Investment Advisors's Teladoc Health position peaked at $5K in Q1 2022.
  • 95 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.